Covid-19 vaccine rollout next week: Detailed checklist has been prepared by the Union Health Ministry and shared with the four states to guide them in the dry run
The Central Government is gearing up for the roll out of the vaccine for Covid-19 across the country. A dry run has been planned in Andhra Pradesh, Assam, Gujarat, Punjab considering the geographical locations. The detailed checklist has been prepared by the Union Health Ministry and shared with the four states to guide them in the dry run.
“To strengthen the capacity of our human resource for COVID-19 vaccine introduction and roll-out, detailed training modules have been developed for different categories of vaccine handlers and administrators including medical officers, vaccinators, alternate vaccinators, cold chain handlers, supervisors, data managers, ASHA coordinators and all others involved in the implementation process at different levels,” the government release said.
2,360 training sessions held; more than 7,000 district trainees trained
2,360 participants were trained during national level Training of Trainers which comprised state immunization officers, cold chain officers, IEC officials, development partners etc. As on date, the State level trainings had been completed in all States/UTs with participation of more than 7000 district level trainees, except Lakshadweep which will conduct it soon (29th Dec). Cascading down, 681 districts (49,604 trainees) have completed the training of Medical Officers on operational guidelines. Vaccination team trainings have been completed in 1399 out of 17831 blocks/ planning units. It is on going in the other blocks.
National, state helpline strengthened
To facilitate redressal of queries on COVID-19 vaccination and Co-WIN portal related queries, national 1075 and state 104 Helpline capacity has also been strengthened to address queries beyond their routine support.
Dry run for vaccine administration in 4 states next week
A dry run has been planned in four states – Andhra Pradesh, Assam, Gujarat, Punjab. Each state will plan it in two districts and preferably in different (five) session type settings e.g. district hospital, CHC/PHC, urban site, private health facility, rural outreach etc. This will exercise enable end-to-end mobilisation and testing of COVID-19 vaccination process (except the vaccine) and check the usage of Co-WIN in field environment, the linkages between planning, implementation and reporting mechanisms and identify challenges and guide way forward prior to actual implementation including improvements that may be required in the envisaged process. This will also provide a hands-on experience to programme managers at various levels. This two-day activity is planned on 28th & 29th December 2020, and will include activities from the necessary data entries in Co-WIN to vaccine receipt & allocation to deployment of team members, mock drill of session sites with test beneficiaries to reporting and evening meeting. This will also include testing for cold storage and transportation arrangements for COVID19 vaccine, management of crowd at the session sites with proper physical distancing.
Three prioritised population groups for Covid-19 vaccine
The National Expert Group on Vaccine Administration of COVID-19 (NEGVAC) has recommended three prioritised population groups including Healthcare Workers (HCWs) (about 1 crore), Frontline Workers (FLWs) (about 2 crore), and Prioritized Age Group (about 27 crore).
Vaccine storage
As vaccines are temperature sensitive and need to be stored in specific temperature, the present cold chain system consisting of 85,634 equipments for storage of vaccine at about 28,947 cold chain points across the country will be used for the cold chain administration. The current cold chain is capable of storing additional quantity of Covid-19 vaccine required for the first 3 Crore prioritised population i.e Health Care Workers and Front Line Workers.
6 vaccine candidates in various stages of the clinical trial in India
The six vaccine candidates which are in various stages of the clinical trial are – Covishield, Covaxin, ZyCoV-D, Sputnik V, NVX-CoV2373 and recombinant protein antigen-based vaccine, according to the Health Ministry.
